Denali Therapeutics Inc (NAS:DNLI)
$ 20.61 -0.71 (-3.33%) Market Cap: 3.07 Bil Enterprise Value: 2.23 Bil PE Ratio: 0 PB Ratio: 2.33 GF Score: 59/100

Denali Therapeutics Inc (DNLI) Transcripts

  • 1